Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting
暂无分享,去创建一个
J. Platts-Mills | Jieng-Lung Liu | E. Houpt | R. Nshama | J. Gratz | Buliga Mujaga | Athanasia Maro | T. McMurry | C. Amour | E. Mduma | Thomas Walongo
[1] J. Buttery,et al. Options for improving effectiveness of rotavirus vaccines in developing countries , 2017, Human vaccines & immunotherapeutics.
[2] H. Dupont,et al. Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas. , 2017, The American journal of tropical medicine and hygiene.
[3] R. Chilengi,et al. Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries , 2016, Clinical and Vaccine Immunology.
[4] U. Parashar,et al. Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction , 2016, The Journal of infectious diseases.
[5] W. D. de Vos,et al. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana , 2016, The Journal of infectious diseases.
[6] Ashutosh Kumar Singh,et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.
[7] Fatima Aziz,et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study , 2016, The Lancet.
[8] R. Haque,et al. Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] G. Kang,et al. Optimization of Quantitative PCR Methods for Enteropathogen Detection , 2016, PloS one.
[10] A. L. Bourgeois,et al. Status of vaccine research and development for enterotoxigenic Escherichia coli. , 2016, Vaccine.
[11] J. Tate,et al. Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] U. Parashar,et al. Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] J. Tate,et al. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Stanley K Diamenu,et al. Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Manish M Patel,et al. Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] S. Madhi,et al. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] J. Tate,et al. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] A. Costello,et al. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] J. Tate,et al. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis. , 2016, The Lancet. Global health.
[20] U. Parashar,et al. A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants , 2016, The Journal of infectious diseases.
[21] Mustafizur Rahman,et al. Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial , 2016, The Journal of infectious diseases.
[22] U. Parashar,et al. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] M. Carolina Danovaro-Holliday,et al. Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador , 2015, Vaccine.
[24] Mark A. Miller,et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.
[25] E. Svensen,et al. Frequent brief on-site simulation training and reduction in 24-h neonatal mortality--an educational intervention study. , 2015, Resuscitation.
[26] A. Costello,et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study , 2015 .
[27] Shihab U. Sobuz,et al. Molecular genotyping and quantitation assay for rotavirus surveillance. , 2015, Journal of virological methods.
[28] R. Walker,et al. Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infants. , 2015, Vaccine.
[29] S. Madhi,et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study. , 2014, The Lancet. Infectious diseases.
[30] E. Svensen,et al. The etiology, risk factors, and interactions of enteric infections and malnutrition and the consequences for child health and development study (MAL-ED): description of the Tanzanian site. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] Shihab U. Sobuz,et al. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. , 2014, The Lancet. Infectious diseases.
[32] M. Levine,et al. Progress and pitfalls in Shigella vaccine research , 2013, Nature Reviews Gastroenterology &Hepatology.
[33] K. Neuzil,et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. , 2012, Vaccine.
[34] S. Madhi,et al. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. , 2012, Vaccine.
[35] R. Rheingans,et al. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. , 2012, Vaccine.
[36] M. Riddle,et al. A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. , 2011, Vaccine.
[37] M. Levine,et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet.
[38] M. Levine,et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet.
[39] J. Klena,et al. Design and validation of a multiplex polymerase chain reaction for the identification of enterotoxigenic Escherichia coli and associated colonization factor antigens. , 2010, Diagnostic microbiology and infectious disease.
[40] Manish M Patel,et al. Decline and Change in Seasonality of US Rotavirus Activity After the Introduction of Rotavirus Vaccine , 2009, Pediatrics.
[41] F. Qadri,et al. Development of Multiplex PCR Assays for Detection of Enterotoxigenic Escherichia coli Colonization Factors and Toxins , 2009, Journal of Clinical Microbiology.
[42] N. Grassly,et al. Seasonal infectious disease epidemiology , 2006, Proceedings of the Royal Society B: Biological Sciences.
[43] D. Politis. The Impact of Bootstrap Methods on Time Series Analysis , 2003 .
[44] H Straatman,et al. Studying seasonality by using sine and cosine functions in regression analysis. , 1999, Journal of epidemiology and community health.